Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
HIV/AIDS and Maternal and Child Health Programs in Resource-Limited Settings Paula E. Brentlinger, MD, MPH Department of Global Health January 2012 Today’s Plan The epidemic in women and children Antiretroviral medications for treatment and prevention Treatment: Other considerations in women and children Real-world barriers to implementation Calls to action HIV Epidemiology in Women and Children: 1970s to present Onset of AIDS Epidemic (US Data) “Since 1981, an outbreak of acquired immune dysfunction manifested by opportunistic infections and neoplastic disorders such as Kaposi’s sarcoma and malignant lymphomas has been reported in more than 1000 homosexual men.” Metroka CE et al. Generalized lymphadenopathy in homosexual men. Ann Int Med 1983;99:585-91. Women, HIV, and Western Washington “Living in Olympia I felt alone, like I was the only woman in town with this disease [AIDS]. I got a lot of support from all of the wonderful gay men....I attended their support group every week, but felt I needed another woman to talk with, someone who could identify with having kids.” “Anna B.” Reflections on taking pills, being a mom, and living in a rural community. STEP Perspective, 1998;98(2):7. (STEP: Seattle Treatment Education Program) HIV and Women in Africa “Antibody to human T-cell lymphotrophic virus type III (HTLV-III) was detected in the serum of 66% of prostitutes of low socioecononomic status............the relatively high female:male ratio of cases of AIDS in Africa (1:1 in Zaire, compared with 1:16 in the United States)...raises the possibility that perinatal transmission may result in high rates of the infection among infants and children...” Kreiss JK et al. AIDS virus infection in Nairobi prostitutes. N Engl J Med 1986;314:414-8. The current numbers: 34 million living with HIV in 2010 (WHO 2011) Half of Adults with HIV are Women (59% in sub-Saharan Africa) (WHO 2011) Likelihood of MTCT (UNICEF: Children and AIDS: Fifth Stocktaking Report, 2010) 3.4 Million Children Under 15 Living with HIV 2010 (90% in Africa) (WHO 2011) Distribution of new infections by mode of exposure in Ghana and Swaziland, 2008 100 No risk Medical injections 80 Blood transfusions Injecting drug use (IDU) Partners IDU 60 Sex workers % Clients Partners of Clients 40 Men who have sex with men (MSM) Female partners of MSM Engaged in casual sex (CS) 20 Partners of CS Low-risk heterosexual 0 Ghana Swaziland 1Swaziland 2 Note: sensitivity analysis for Swaziland used different data sources. Sources: Bosu et al. (2009) and Mngadi et al. (2009). Figure 3 Distribution of HIV Incidence by Mode of Exposure Distribution of Reported HIV Infections by Mode of Exposure 1990s & Onward: Antiretrovirals for Treatment and Prevention! ARV: Antiretroviral (medication) HAART: Highly active antiretroviral therapy (later called cART) PMTCT: Prevention of mother-to-child transmission Survival and Antiretroviral Therapy (HAART) in Adults with AIDS Impact of HAART in South Africa Medecins sans Frontieres project in Khayelitsha: Of 1st 287 adult patients started on HAART, 86.3% still alive at 24 months Median CD4 count gain 288 at 24 months Viral load < 400 copies/ml in 69.7% of patients at 24 months Coetzee D, et al. AIDS 2004. Mortality on HAART: developed vs. developing countries (from ART-LINC) Special Considerations re ARV use in Women of Reproductive Age Some ARVs are probably teratogenic (based on animal studies) and should not be given in pregnancy or to women at risk of pregnancy. Some ARVs appear to have increased toxicity in pregnancy (e.g. DDI and D4T in combination). Some ARV side effects more common in women (e.g. nevirapine rash and hepatotoxicity). Drug-drug interactions involving contraception and ARVs (?) Drug resistance risk if starting/stopping with each pregnancy Perinatal Infection and Survival (before the era of treatment) Cohort of HIV-infected children born between 1979 and 1987, Florida: “The median survival time of all 172 children was 38 months from the time of diagnosis. Mortality was highest in the first year of life (17%).....children with perinatally acquired HIV-1 infection have a very poor prognosis.” Scott GB et al. Survival in children with perinatally acquired human immunodeficiency virus type-1 infection. N Engl J Med 1989;321:1791-6. AIDS and Mortality in South African Children Cause-specific mortality in South Africa: Age group 0-28 days 29 days – 1 year 1-4 years* 5-9 years* 10-14 years* % deaths from AIDS 5.0% 34.0% 61.0% 33.0% 17.0% * Most common cause of death in this age group Garrib A et al, 2006. Survival and HAART in Children:CHER (Violari et al, NEJM 2008) CHER, cont’d HIV, HAART, Pediatric Neurodevelopmental Outcomes J of AIDS 2012;59:161-9) (Heidari S et al., Special Considerations re ART in Children 1. HIV infection progresses very rapidly (months to a few years) to AIDS and death in infants; early diagnosis and treatment are essential 2. Dosing is different in children because of differences in weight and drug metabolism; increase dose as child grows; gaps in PK data 3. Liquid formulations of ARVs for kids are harder to acquire and handle than pill formulations for adults 4. Importance of neurodevelopmental outcomes 5. Importance of caregivers Antiretrovirals and Prevention: PMTCT. The 1st PMTCT Trial (PACTG 076) Monotherapy with zidovudine (AZT) in late pregnancy reduced HIV transmission during pregnancy and childbirth by 67% (25.5% with placebo vs. 8.3% with zidovudine) in PACTG 076 trial. Connor E, N Engl J Med 1994. MTCT at Age 6 Weeks by ARV Regimen Botswana National Data Oct 2006-Nov 2007 Tlale J et al. IAS Mexico City Aug 2008 (Abs ThAC04), quoted in Mofenson L 2008 15% Most Women Formula Feed Their Infants 12.3% 10% 5% 7.0% 4.7% 0.7% 0% 3.3% 5.5% 3.1% 2.3% HAART HAART AZT AZT AZT sdNVP No AZT ART pre-preg during >4 wk >4wk <4 wk <4 wk preg +sdNVP alone +sdNVP alone 6 Month vs. 6 Week NVP (Coovadia HM et al, Lancet 2012;379:221-8) Earlier vs. Later Maternal HAART (Chibwesha CA et al, J of AIDS 2011;58:224-8) Infant Mortality, Maternal HAART, Breast-feeding (Homsy et al, JAIDS Jan 2010) WHO Policy, 2009: The Radical Changes Mothers known to be HIV-infected should be provided with lifelong antiretroviral therapy or antiretroviral prophylaxis interventions to reduce HIV transmission through breastfeeding according to WHO recommendations. Mothers known to be HIV-infected should exclusively breast feed their infants for the first 6 months of life, introducing appropriate complementary foods thereafter, and continue breast-feeding for the first 12 months of life. Antiretrovirals and Prevention: Sexual Transmission (Celum&Baeten, Curr Opin Infect Dis 2012;25(51-7) Prevention: Microbicides (2) Tenofovir gel PrEP: Aspects Specific to Women Vaginal vs. blood concentrations of drug Female-controlled (unlike condom use) Drug interactions involving oral PrEP and hormonal contraceptives (?????) In the pipeline: drug-eluting vaginal rings? HIV Prevention: Other Considerations in Women and/or Children Other Considerations in PMTCT (1) Prevention of unwanted pregnancies is the first step in PMTCT! Other Considerations in PMTCT (2): Obstetrical Interventions An incomplete list of obstetrical interventions or choices that increase likelihood of vertical transmission: o Choosing prolonged labor over caesarean delivery (especially with prolonged rupture of membranes) o Episiotomy o Placement of internal monitors o Artificial rupture of membranes o Forceps deliveries o Transfusions with unscreened/infected blood Other Considerations in PMTCT (3): Vertical HIV Transmission and Placental Malaria (Brahmbhatt 2008) Prevention: Male Circumcision Male circumcision prevents sexual transmission of HIV to uninfected men, but: In Uganda, serodiscordant (husband HIV+, wife HIV-) randomized to circumcision vs none: HIV transmission to wives 13.8/100 py in circumcision group 9.6/100py in non-circumcision group Wawer et al, CROI abstract 33 LB, 2008 Prevention: Condoms work if used Some successful targeted condom programs: • Targeted condom promotion (condom distribution plus individual and group counseling) in female commercial sex workers in Kenya. Condom use associated with threefold reduction of risk of HIV seroconversion. • Condom use and HIV education in female sex workers in India led to decreased HIV incidence (by about 67%) in intervention group. • Targeted condom distribution and HIV education in male army conscripts in Thailand led to 50% reduction in HIV incidence. Merson M, et al. AIDS 2000. Prevention: Voluntary Counseling & Testing for HIV (VCT) Some aftermath of VCT: For women who were HIV+ and disclosed their status to a partner: 14% reported break-up of marriage, 26% breakup of sexual relationship, 7% physical abuse, 3% neglected or disowned by family (vs. 1%, 14%, 4%, and 2% if HIV-negative and disclosed). Grinstead O, et al. AIDS 2001. “Cheap Solutions Cut AIDS Toll for Poor Kenyan Youths” (NYT, 6 Aug 2006) “....when girls were given free school uniforms instead of having to pay $6 for them – the principal remaining economic barrier to education in Kenya – they were significantly less likely to drop out and become pregnant...” “...classroom debates and essay-writing contests on whether students should be taught about condoms to prevent HIV increased the use of condoms without increasing sexual activity...” HIV/AIDS Treatment: Other Considerations in Women and Children Growth and HIV exposure (Filteau et al) Orphans and school attendance (from UNICEF, 2010) Infant growth vs water supply (Patel et al.) Real-World Barriers to Coverage of Prevention and Treatment ART Coverage The PMTCT cascade (Braun et al) Pediatric early diagnosis in Mozambique (Cook et al.) Calls to Action The Call to Action (UNICEF, 2010) 1. Change the PMTCT focus from coverage of ARV prophylaxis to the health of mothers and the HIV-free survival of children. 2. Make exclusive breast-feeding safe and sustainable. 3. Identify HIV positive newborns, children and young people without delay and provide rapid access to ART for those eligible. 4. Make children and adolescents central to the development and implementation of promising new prevention strategies. 5. Redress low levels of knowledge about HIV. 6. Increase access of children and adolescents living on the margins of society to health, education, and social welfare services. 7. Provide economic support to poor and vulnerable women, children and adolescents. 8. Prevent violence and abuse of women and girls and enforce laws against it. Integrate Services Harmonize the MDGs (Waage et al 2010) Thank you! Questions????